Combining bioinformatics analyses and biological function validation, our study provides evidence that NCAPG was elevated in lung cancer, and its high expression was correlated with poor clinical-pathological features, including the pathologic stage, TNM stage, primary therapy outcome, gender, and smoking status. Here, NCAPG is linked to lung carcinoma.